ATE419833T1 - Modulares zielgerichtetes liposomales verabreichungssytem - Google Patents

Modulares zielgerichtetes liposomales verabreichungssytem

Info

Publication number
ATE419833T1
ATE419833T1 AT00980515T AT00980515T ATE419833T1 AT E419833 T1 ATE419833 T1 AT E419833T1 AT 00980515 T AT00980515 T AT 00980515T AT 00980515 T AT00980515 T AT 00980515T AT E419833 T1 ATE419833 T1 AT E419833T1
Authority
AT
Austria
Prior art keywords
linking
moiety
modular
delivery system
moieties
Prior art date
Application number
AT00980515T
Other languages
English (en)
Inventor
Paul Meers
Tong Shangguan
Donna Cabral-Lilly
Patrick Ahl
Ravi Erukulla
Andrew Janoff
Original Assignee
Transave Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transave Inc filed Critical Transave Inc
Application granted granted Critical
Publication of ATE419833T1 publication Critical patent/ATE419833T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Catching Or Destruction (AREA)
  • Feeding And Watering For Cattle Raising And Animal Husbandry (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Control Of Eletrric Generators (AREA)
  • Beverage Vending Machines With Cups, And Gas Or Electricity Vending Machines (AREA)
  • Mobile Radio Communication Systems (AREA)
AT00980515T 1999-11-24 2000-11-17 Modulares zielgerichtetes liposomales verabreichungssytem ATE419833T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16729799P 1999-11-24 1999-11-24
US20908800P 2000-06-02 2000-06-02

Publications (1)

Publication Number Publication Date
ATE419833T1 true ATE419833T1 (de) 2009-01-15

Family

ID=26863035

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00980515T ATE419833T1 (de) 1999-11-24 2000-11-17 Modulares zielgerichtetes liposomales verabreichungssytem

Country Status (8)

Country Link
EP (1) EP1231895B1 (de)
JP (1) JP2003514843A (de)
AT (1) ATE419833T1 (de)
AU (1) AU1776801A (de)
CA (1) CA2391606A1 (de)
DE (1) DE60041351D1 (de)
ES (1) ES2320193T3 (de)
WO (1) WO2001037807A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0205786D0 (en) * 2002-03-12 2002-04-24 Regma Bio Technologies Ltd Novel Composition
EP1676588B1 (de) * 2003-10-01 2013-12-11 Japan Science and Technology Agency Polyarginin-modifiziertes Liposom, welches zellkerngängig ist
US7521425B2 (en) * 2005-03-03 2009-04-21 Covx Technologies Ireland Limited Anti-angiogenic compounds
DE602006007846D1 (de) * 2006-08-31 2009-08-27 Nestec Sa Interaktion zwischen Nahrungeiweiss und geladene Emulgator
EP2068832A2 (de) * 2006-09-11 2009-06-17 Medtronic, Inc. Pharmazeutische mittel enthaltende liposomkomplexe und verfahren
EP2100597A3 (de) * 2008-03-11 2009-12-30 Medtronic, Inc. Liposomkomplexe
WO2013093891A1 (en) 2011-12-22 2013-06-27 Nuvo Research Gmbh Liposomal chlorite or chlorate compositions
JP2016524621A (ja) * 2013-06-03 2016-08-18 バル−イラン ユニバーシティ ウィスコットアルドリッチ症候群タンパク質を変調するリポソーム
CN105169404B (zh) * 2015-09-02 2018-06-26 上海市普陀区中心医院 一种用于治疗去势抵抗性前列腺癌的靶向前药及其纳米制剂和制备方法
EP3225246A1 (de) * 2016-03-31 2017-10-04 Klinikum der Universität München Synthetische verbindung zur verbesserung der effizienz der transfektion
WO2018087720A1 (en) 2016-11-14 2018-05-17 Novartis Ag Compositions, methods, and therapeutic uses related to fusogenic protein minion

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897873A (en) * 1984-04-12 1999-04-27 The Liposome Company, Inc. Affinity associated vaccine
US5820873A (en) * 1994-09-30 1998-10-13 The University Of British Columbia Polyethylene glycol modified ceramide lipids and liposome uses thereof
TW520297B (en) * 1996-10-11 2003-02-11 Sequus Pharm Inc Fusogenic liposome composition and method
US5935599A (en) * 1996-10-28 1999-08-10 The Board Of Trustees Of The University Of Illinois Polymer-associated liposomes for drug delivery and method of manufacturing the same

Also Published As

Publication number Publication date
WO2001037807A1 (en) 2001-05-31
AU1776801A (en) 2001-06-04
ES2320193T3 (es) 2009-05-20
EP1231895B1 (de) 2009-01-07
DE60041351D1 (de) 2009-02-26
EP1231895A4 (de) 2006-06-07
JP2003514843A (ja) 2003-04-22
EP1231895A1 (de) 2002-08-21
CA2391606A1 (en) 2001-05-31

Similar Documents

Publication Publication Date Title
EP1198256A4 (de) Peptid-lipid-konjugate, liposomen und liposomale medikamentenverabreichung
HUP0000150A2 (en) Peptide-lipid conjugates,liposomes and liposomal drug delivery
MXPA02012068A (es) Formulaciones liposomales inhibidoras de la timidilato de benzoqunazolina sintasa.
AU4357800A (en) Intracellular pharmaceutical targeting
DE69730218D1 (de) Fusogene liposomen
DE69708919D1 (de) Neue liposomkomplexe mit erhöhter systemischer verabreichung
WO2002097116A3 (en) Delivery system for nucleic acids
AU4496900A (en) Improved drug delivery pack
AU2001283357A1 (en) Drug delivery system with bilayer electrodes
AU3999699A (en) Targeted liposomal drug delivery system
AU5060499A (en) Hydrodynamically balanced oral drug delivery system
IL152593A0 (en) Liposome drug delivery
ATE419833T1 (de) Modulares zielgerichtetes liposomales verabreichungssytem
WO2001049266A3 (en) Iron chelator delivery system
HUP0203117A3 (en) Neutral-cationic lipid for nucleic acid drug delivery
DE69830249D1 (de) Zielgerichtete liposomen zur verabreichung von genen
AU2001270963A1 (en) Transdermal drug delivery system
ATE318834T1 (de) Lipide mit aminoxygruppe
AU2002222138A1 (en) Drug delivery system
AU2002210580A1 (en) Drug delivery system
AU5429699A (en) Drug targeting
HK1050843A (en) Modular targeted liposomal delivery system
AU2574600A (en) Liposome preparations containing antitumor drug
AUPR170800A0 (en) Therapeutic conjugates for the delivery of polycationic drugs
HK1050494A (en) New self emulsifying drug delivery system

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties